Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A scoping review shows that several nonvalidated budget planning tools for randomized trials are available
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4525708
Author(s) Speich, Benjamin; Gloy, Viktoria; Schur, Nadine; Ewald, Hannah; Hemkens, Lars G.; Schwenkglenks, Matthias; Briel, Matthias; MAking Randomized Trials Affordable Group,
Author(s) at UniBasel Schwenkglenks, Matthias
Schur, Nadine
Ewald, Hannah
Hemkens, Lars G.
Briel, Matthias
Year 2020
Title A scoping review shows that several nonvalidated budget planning tools for randomized trials are available
Journal Journal of Clinical Epidemiology
Volume 117
Pages / Article-Number 9-19
Keywords Budget planning; Clinical trial cost; Randomized clinical trials; Resource use; Scoping review; Template
Abstract We aimed to provide a systematic overview of freely available tools which may help plan or monitor costs for randomized clinical trials (RCTs).; We systematically searched MEDLINE, EMBASE, and EconLit and conducted internet searches via Google (last search, October 2018). We included all freely available tools and determined their specific purpose, which parts of clinical trial projects and which types of costs they covered, and if they were user-tested or validated in any form.; We identified 25 available tools. Most tools were downloadable on websites from institutions related to clinical research. Seven tools were developed to plan the budget for an entire RCT, 17 tools for calculating budgets of an individual trial center, and one tool for monitoring costs of ongoing RCTs. Eighteen tools considered fixed, variable, and indirect costs. Only two tools were clearly user-tested or validated.; Several freely available tools aim to support investigators in planning costs of an entire trial or in planning the budget for a clinical trial site. How valid and useful they are remains to be shown for most of them. Future tools should be openly shared, user-tested, and validated.
Publisher Elsevier
ISSN/ISBN 0895-4356 ; 1878-5921
edoc-URL https://edoc.unibas.ch/74370/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jclinepi.2019.09.009
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31533072
 
   

MCSS v5.8 PRO. 0.357 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/04/2024